Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cytokine Rich Serum vs Arthroscopic Resection for Lateral Epicondylitis
NCT04194710Unknown
- Sponsor
- Hospital Universitari Parc Taulí
- Start
- Dec 2020
- Primary completion
- Jul 2023
- Modality
- Biologic
- Countries
- 1
01
Overview
Randomised, open-label trial of autologous conditioned serum in Lateral Epicondylitis (LET), sponsored by Hospital Universitari Parc Taulí. Primary endpoint: Pain assessment at 6 months. Status: unknown.
02
Drugs
autologous conditioned serum
03
Conditions
Lateral Epicondylitis (LET)
Beyond the preview
Go deeper on NCT04194710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04194710.